Borrower record · Q2 2026
Wellspring Pharmaceutical
As filed by 2 BDCs · period end 30 June 2026Filers label it: Healthcare & Pharmaceuticals (2)
Two lenders report $37.7m of Wellspring Pharmaceutical at Q2 2026, marked at par. First-Lien Senior Secured on all nine positions whose seniority a filer disclosed.
- Filed fair value
- $37.7m
- 9 funded positions
- Reporting lenders
- 2
- across 9 filed positions
- Aggregate mark
- 100.2c
- cost filed on all 9 positions
- Median spread
- 450bp
- over SOFR, 9 tranches
- Maturities to
- 2028
- one date, 22 August 2028
- Periods on record
- 5
- Q2 2025 → Q2 2026
How this total is counted
- Every figure above is the sum of 9 funded positions filed by 2 BDCs, each one cited below.
- Counted from the Q2 2026 filings imported for this build, the latest of them filed 20 August 2026. A schedule filed after that date is not in these figures and will appear when the property is rebuilt.
Pricing as filed
9 floating tranches · SOFR450bp on all 9 floating tranches — every filer reports the same spread.
Capital structure
First-Lien Senior Secured, on all 9 positions whose seniority a filer disclosed.
Rate structure
Floating, on all 9 positions whose interest type a filer disclosed.
Maturity profile
all 9 funded positions dated2.1 years to maturity, weighted by fair value across the 9 dated positions.
Filed over time
5 periods · aggregate onlyFiled fair value
Aggregate marknot to zero
Q2 2025, Q3 2025, Q4 2025, Q1 2026, Q2 2026 — every filer reporting the borrower at each period, aggregated. No lender is separated out at any period.
Credit flags
No lender reports this borrower on non-accrual, and no filed tranche pays in kind.
Not in the filings
- No sector. 2 filers file the same industry string, shown above as filed, but it has not cleared the corroboration test.
- No mark dispersion. Fewer than four filers disclosed a cost, so the distance between the highest and lowest mark would place each of them.
- No index floor filed on any tranche.
Sign up for free
Who holds it, and where they mark it.
2 lenders hold the same credit and mark it differently. Behind the gate, one row each — for this borrower and for every other one on this site, free and with no limit on how many you read.
- The spread between the highest and lowest lender mark
- Quarter-on-quarter movement across 5 periods
- Peer comparison against borrowers with the same lenders
- The 10-Q or 10-K behind every row, by accession number
Every filing behind this page
2 filers · Q2 2026| Filer | CIK | Form | Period | Filed | Accession |
|---|---|---|---|---|---|
| Nuveen Churchill Direct Lending Corp. (NCDL) | 0001737924 | 10-Q | 2026-06-30 | 2026-08-06 | 0001737924-26-000084 |
| Nuveen Churchill Private Capital Income Fund | 0001911066 | 10-Q | 2026-06-30 | 2026-08-12 | 0001628280-26-055912 |
Related borrowers
Same lenders